Skip to main content
Abraham Chachoua, MD, Oncology, New York, NY

AbrahamChachouaMDFRACP

Oncology New York, NY

Hematologic Oncology, Thoracic Cancer

Associate Professor of Medicine, NYU School of Medicine

Dr. Chachoua is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chachoua's full profile

Already have an account?

  • Office

    160 E 34th St
    New York, NY 10016
    Phone+1 212-731-5165
    Fax+1 212-263-8460

Education & Training

  • Monash University Faculty of Medicine
    Monash University Faculty of MedicineClass of 1979

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1989 - 2025

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2007-2014
  • New York Magazine: Top Doctors Castle Connolly, 2007-2009, 2012-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Radiotherapy Induces Responses of Lung Cancer to CTLA-4 Blockade  
    Abraham Chachoua, Silvia C Formenti, Benjamin Cooper, Kent Friedman, Sandra Demaria, Nature

Press Mentions

  • Franco Muggia, a Drug Developer and Former Director of NYU Langone’s Perlmutter Cancer Center, Died Unexpectedly on Sept. 8
    Franco Muggia, a Drug Developer and Former Director of NYU Langone’s Perlmutter Cancer Center, Died Unexpectedly on Sept. 8September 17th, 2021
  • NYU Langone Brings Top Talent to Advance Cancer Care in Brooklyn
    NYU Langone Brings Top Talent to Advance Cancer Care in BrooklynMarch 11th, 2021
  • Around Brooklyn: BP Adams Joins Anti-Diabetes Effort
    Around Brooklyn: BP Adams Joins Anti-Diabetes EffortNovember 17th, 2020
  • Join now to see all

Grant Support

  • Su101 In Patients W/ Psa+ Prostate Cancer(101 008)National Center For Research Resources1999–2002
  • Cisplatin Analog In Malignant Pleural MesotheliomaNational Center For Research Resources2000
  • IL-1 Combined With High Dose Cisplatinum For Metastatic MelanomaNational Center For Research Resources1995–1996
  • Evaluations Of Cytokine And Chemotherapy CombinationsNational Cancer Institute1992–1994
  • Recombinant Human Interleukin-1 In Refractory Carcinoma PatientsNational Center For Research Resources1993
  • Gmcsf And Murine Monoclonal Antibody R24 For Metastatic MelanomaNational Center For Research Resources1992–1993
  • Recombinant Human Interleukin 1 In Refractory Carcinoma PatientsNational Center For Research Resources1991–1992
  • Phase II Trial Of Bropirimine In Aids/KsNational Center For Research Resources1988

Professional Memberships